Abstract:OBJECTIVE:To investigate the role of telomerase in the development of ovarian carcinoma, and to ascertain the co-relationship between telomerase activity and clinical-pathological factors.METHODS:The telomerase repeat amplification protocol (TRAP) assay was used to examine telomerase activity in forty-five ovarian tumors and nine normal ovarian tissues.RESULTS: The positive rates of ovarian carcinoma and borderline ovarian tumors were 83.33%( 25/30) and 5/7 respectively, but none of the benign ovarian tumors and normal ovarian tissues was detected to have telomerase activity, P=0.596 3. The positive rates of telomerase activity in ovarian carcinoma and borderline ovarian tumors were significantly higher than those in benign and normal tissues,P0.01. No relationship was found between the expression of telomerase activity and the clinical factors.CONCLUSION:Telomerase activation may contribute to the progression of ovarian carcinoma, and can probably become a promising target for gene therapy in ovarian carcinoma.

Expression of Telomerase Activity and Its Relationship with Clinical-Pathological Factors in Epithelial Ovarian Tumors